Enveric Biosciences Inc vs Figs Inc — how do they compare? Enveric Biosciences Inc trades at $1.32 (market cap $5.32M), while Figs Inc trades at $10.24 (market cap $1.66B). The key difference: Figs Inc is far larger — about 312× Enveric Biosciences Inc's market cap, and Figs Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | FIGS | |
|---|---|---|
Market Cap | $5.32M | $1.66B |
Sector | Health | Consumer Cyclical |
52-Week High | $17.40 | $17.12 |
52-Week Low | $1.28 | $5.81 |
Enterprise Value | $408.82K | $1.44B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
FIGS trades at $9.72, down 2.8% today, amid bearish technical signals despite recent earnings beats. Revenue grew to $631M in 2025 with a 66.6% gross margin, but net cash flow remains negative. Analyst consensus is bullish with a $19.50 price target, though technical indicators show selling pressure with RSI at neutral levels and ADX signaling a strong downtrend.
The stock presents a growth opportunity with strong fundamentals and analyst support, but faces near-term technical headwinds and margin pressures from tariffs and freight costs. Investors should weigh the 100% upside to consensus target against execution risks and persistent negative cash flow trends.
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →FIGS Inc is a healthcare apparel company. It offers more fitted scrubs for men and women made of its proprietary fabric FIONx, which provides four-way stretch and has anti-odor, anti-wrinkle, and moisture-wicking properties.
Read more on FIGS →